Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nirban Basu

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Gynecologic Oncology|May 24, 2024
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancerChinmoy K Bose, Nirban Basu
Journal of the Turkish German Gynecological Association|June 23, 2015
PARP inhibitors and moreChinmoy K Bose, Nirban Basu
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Gynecologic Oncology|May 24, 2024
Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancerChinmoy K Bose, Nirban Basu
Journal of the Turkish German Gynecological Association|June 23, 2015
PARP inhibitors and moreChinmoy K Bose, Nirban Basu
Pageof 1